+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
RPGLIFE

RPG Life Sciences Share Price

₹2,782.30 -48.2 (-1.7%)
60.55% Gain from 52W Low

14 Aug, 2026 3:53 PM (IST)

RPG Life Sciences live price: ₹2,782.30. It opened at ₹2,831 vs previous close ₹2,831; intraday high/low: ₹2,843/₹2,758. The 50 & 200 DMA stand at ₹2,608.20/₹2,333.40.

RPG Life Sciences Performance

  • Today's Low
  • ₹2,758
  • Today's High
  • ₹2,843
  • 52 Week Low
  • ₹1,733
  • 52 Week High
  • ₹3,082
  • Open Price₹2,831
  • Previous Close₹2,831
  • Volume15,301
  • 50 DMA₹2,608.20
  • 100 DMA₹2,448.60
  • 200 DMA₹2,333.40

RPG Life Sciences Chart

Investment Returns

  • Over 1 Month -1.44%
  • Over 3 Month + 19.25%
  • Over 6 Month + 40.9%
  • Over 1 Year + 21.95%

Smart Investing Starts Here Start SIP with RPG Life Sciences for Steady Growth!

Invest Now

RPG Life Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 38.5
  • PEG Ratio
  • -
  • Market Cap Cr
  • 4,602
  • P/B Ratio
  • 7.6
  • Average True Range
  • 119.5
  • EPS
  • 72.3
  • Dividend Yield
  • 0.9
  • MACD Signal
  • 20.7
  • RSI
  • 55.31
  • MFI
  • 34.41

Latest Stock News Updates

RPG Life Sciences Ltd - 532983 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the details of the Analyst/Institutional Investors meet to be attended by the Company are enclosed.

RPG Life Sciences Ltd - 532983 - Announcement under Regulation 30 (LODR)-Change in Management

Intimation on superannuation of Senior Management Personnel

RPG Life Sciences Ltd - 532983 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper advertisement in respect to Special window opened for lodgement of transfer and dematerialization request(s).

RPG Life Sciences Financials

RPG Life Sciences Technicals

EMA & SMA

Current Price
₹2,782.30
-48.2 (-1.7%)
pointer
  • Bearish Moving Average 1
  • Bullish Moving Average 15
  • 20 Day
  • ₹2,733.30
  • 50 Day
  • ₹2,608.20
  • 100 Day
  • ₹2,448.60
  • 200 Day
  • ₹2,333.40

Resistance and Support

2794.37 Pivot Speed
  • R3 2,916.10
  • R2 2,879.60
  • R1 2,830.90
  • S1 2,745.70
  • S2 2,709.20
  • S3 2,660.50

RPG Life Sciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-07-28 Quarterly Results
2026-04-29 Audited Results & Final Dividend
2026-01-27 Quarterly Results
2025-10-17 Quarterly Results
2025-07-25 Quarterly Results
Date Purpose Remarks
2026-07-09 FINAL Rs.24.00 per share(300%)Final Dividend
2025-06-27 SPECIAL Rs.4.00 per share(50%)Special Dividend
2025-06-27 FINAL Rs.20.00 per share(250%)Final Dividend
2024-06-28 FINAL Rs.16.00 per share(200%)Final Dividend
2023-07-21 FINAL Rs.12.00 per share(150%)Final Dividend
View RPG Life Sciences Dividend History Arrow

RPG Life Sciences Shareholding Pattern

72.95%
17.42%
8.64%
0.95%
0.04%

About RPG Life Sciences

RPG Life Sciences is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). View More
  • NSE Symbol
  • RPGLIFE
  • BSE Symbol
  • 532983
  • ISIN
  • INE105J01010

Similar Stocks to RPG Life Sciences

RPG Life Sciences FAQs

RPG Life Sciences share price is ₹2,782 As on 15 August, 2026 | 00:15

The Market Cap of RPG Life Sciences is ₹4601.6 Cr As on 15 August, 2026 | 00:15

The P/E ratio of RPG Life Sciences is 38.5 As on 15 August, 2026 | 00:15

The PB ratio of RPG Life Sciences is 7.6 As on 15 August, 2026 | 00:15

The 52 week High & Low of RPG Life Sciences is ₹3082/₹1733 respectively As on 15 August, 2026 | 00:15

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23